Concerns are mounting over the circumstances surrounding the tragic death of model Presley Gerber, 27, who reportedly received a ketamine prescription from his doctor despite a known history of addiction to the substance. Sources close to Gerber indicate that friends are expressing significant anger, suggesting that the physician who authorized the prescription should face legal repercussions following Gerber’s passing at a Santa Monica rehabilitation facility on September 20, 2026. The incident has cast a shadow over medical prescribing practices and highlights the complex challenges faced by individuals struggling with substance abuse, particularly those in the public eye.
The Emerging Controversy Around Ketamine Prescription
The core of the controversy centers on the alleged prescription of ketamine to Presley Gerber, the son of supermodel Cindy Crawford and businessman Rande Gerber. Insiders told TMZ that ketamine was a "regular problem" for Presley, and his doctor was reportedly aware of his ongoing struggles with drug addiction. This revelation has fueled outrage among Gerber’s inner circle, who believe the doctor’s actions were negligent and potentially criminal. Their calls for prosecution underscore the gravity of the situation and the perceived breach of medical responsibility.
Ketamine, while gaining recognition for its therapeutic potential in treating severe depression and other mental health conditions, is also a controlled substance with a significant potential for abuse. Its use for mental health treatment is often considered "off-label," meaning it’s prescribed for conditions other than those for which it received initial FDA approval. Crucially, it is not FDA-approved as a treatment for substance abuse itself. This distinction is critical in understanding the ethical and medical debate now unfolding around Gerber’s case.
A Life Cut Short: Presley Gerber’s Struggles and Tragic End
Presley Gerber’s death at such a young age has sent shockwaves through the entertainment industry and among those who followed his burgeoning modeling career. Born into a prominent family, Gerber, like many children of celebrities, navigated the intense scrutiny of public life from an early age. Despite his privileged background and opportunities in fashion, he openly struggled with mental health issues and substance abuse for several years leading up to his death.
Friends and sources close to Gerber have painted a picture of a young man grappling with deep-seated insecurities. One insider revealed to Page Six that Gerber "had not been doing well" and "always suffered from a huge lack of self-esteem and had trouble accepting his real self and feeling fully confident in who he was as a person." This internal turmoil often manifested in visible ways, including numerous tattoos that some interpreted as outward expressions of his inner battles. Despite these challenges, the source emphasized that Gerber "wanted so, so badly to be free of his addictions," underscoring his desire for recovery.
Timeline of Events Leading to a Suspected Overdose
The final days of Presley Gerber’s life unfolded rapidly, culminating in his tragic death at a rehabilitation center. On Saturday, September 19, 2026, just one day before his passing, Gerber checked himself into a Santa Monica, California, rehab facility. Reports indicate that he "did not appear sober" upon his arrival, suggesting he was already in a compromised state when he sought professional help.
The following day, September 20, emergency services were called to the rehab center regarding an unresponsive male. According to 911 dispatch audio, Gerber had suffered cardiac arrest. Authorities arriving on the scene attempted life-saving procedures, but their efforts were ultimately unsuccessful. Presley Gerber was pronounced dead at the scene approximately 10 minutes after the initial call was placed, marking a devastating end to his struggle.
Official Investigations and Pending Determinations
The Santa Monica Police Department immediately launched an investigation into Presley Gerber’s death, classifying it as a "suspected overdose." While the official cause and manner of death remain pending, law enforcement officials have stated that there is "no indication of foul play" at this time. This initial assessment suggests that external criminal activity is not believed to be a factor in his passing, shifting focus toward the medical and personal circumstances involved.
An autopsy was performed by the Los Angeles County Department of Medical Examiner, but a definitive determination on the cause of death has been "deferred." This deferral signifies that additional testing and/or studies, likely including comprehensive toxicology reports, have been requested to ascertain precisely what led to Gerber’s cardiac arrest and subsequent death. Such detailed analyses can take weeks or even months to complete, leaving his family, friends, and the public awaiting concrete answers. The results of these tests will be crucial in determining if the prescribed ketamine, or any other substances, played a direct role in his demise.
The Dual Nature of Ketamine: A Medical Quandary
The role of ketamine in Presley Gerber’s treatment and death brings into sharp focus the drug’s complex and often contradictory profile. Originally developed as an anesthetic, ketamine has gained traction in recent years as a promising, rapid-acting treatment for severe depression, anxiety, and PTSD, particularly for patients resistant to conventional therapies. It works by targeting different neurotransmitter systems than traditional antidepressants, offering a novel approach to mental health care.
However, ketamine is also known for its dissociative properties and has a history of recreational abuse. Its illicit use can lead to psychological dependence, cognitive impairment, and serious physical health risks, including bladder damage and respiratory depression at high doses. The ethical dilemma arises when a drug with such a potential for abuse is prescribed to an individual with a documented history of addiction, especially when that individual has identified the very drug as a "problem" substance. Medical professionals are bound by a duty of care, which includes thoroughly assessing a patient’s history and risks before prescribing controlled medications, particularly those with a known abuse potential.
Broader Implications for Medical Ethics and Addiction Treatment
The tragic death of Presley Gerber, under these reported circumstances, has significant implications for the medical community and the broader conversation around addiction treatment. It raises critical questions about physician responsibility, patient safety, and the regulations governing the prescription of controlled substances. If confirmed that a doctor knowingly prescribed ketamine to a patient with a documented addiction to the drug, it could lead to severe consequences for the physician, including investigations by state medical boards, potential loss of license, and even criminal charges.
Furthermore, this case highlights the ongoing challenges in addressing the addiction crisis, which continues to claim countless lives. While the medical community explores innovative treatments for mental health, the imperative to safeguard vulnerable patients with addiction histories remains paramount. It underscores the need for comprehensive patient evaluations, transparent communication between healthcare providers and patients (and their support systems), and robust oversight of prescribing practices, particularly for drugs with a high potential for misuse.
A Family’s Grief and the Search for Answers
For Cindy Crawford and Rande Gerber, Presley’s parents, his death represents an unimaginable loss. Both have been publicly supportive of their son’s struggles, often expressing their concern and love. The revelation that a prescribed medication may have contributed to his demise adds another layer of complexity and anguish to their grief. While the family has not yet made extensive public statements regarding the specifics of the ketamine prescription, their anguish is palpable, and they are undoubtedly seeking answers as the official investigation proceeds.
The unfolding events serve as a poignant reminder of the pervasive nature of mental health and addiction struggles, even within families of privilege and public prominence. Presley Gerber’s story is a stark illustration of how these battles can cut across all societal strata, leaving behind a legacy of pain and unanswered questions. As authorities continue their investigation and await toxicology results, the public watches, hoping for clarity and for accountability where it is due, reinforcing the critical need for vigilance and ethical practice in healthcare.
